Gut microbial tryptophan metabolites have been confirmed as ligands of AHR and influence the progression of obesity, type 2 diabetes (T2D), hypertension, inflammatory bowel disease (IBD), multiple sclerosis (MS), and Huntington's disease (HD) (16). This evidence concerns the gene AHR and obesity due to melanocortin 4 receptor deficiency.